Sep 26, 2026, 12:43 AM EDT · 11 days ago Did Treace Medical Concepts, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
2026-09-17T21:25:37.000Z · 19 days ago Treace Medical presents results from three clinical studies at AOFAS meeting
Sep 17, 2026, 5:16 PM EDT · 19 days ago Treace Announces Results of Three Clinical Studies Including the Milestone 5-Year ALIGN3D® Study Demonstrating Sustained, Positive Outcomes of the Lapiplasty® Procedure
Sep 15, 2026, 5:06 PM EDT · 21 days ago Treace Highlights Product Innovations and Clinical Data Across its Expanding Foot & Ankle Portfolio at the 2026 AOFAS Annual Meeting
Aug 7, 2026, 7:05 AM EDT · 2 months ago Treace Medical Concepts Reports Second Quarter 2026 Financial Results
Jul 24, 2026, 7:05 AM EDT · 2 months ago Treace to Report Second Quarter 2026 Financial Results on August 7, 2026
Jul 13, 2026, 9:49 AM EDT · 2 months ago Johnson Fistel, PLLP Investigates Claims on Behalf of Long-Term Shareholders of Treace Medical Concepts, Inc. (TMCI)
2026-06-18T11:27:34.000Z · 3 months ago Treace Medical announces first surgical case with HyperPlate XM implant
Jun 18, 2026, 7:05 AM EDT · 3 months ago Treace Announces First Surgical Case with the HyperPlate™ XM Dynamic Compression Locking Implant System
May 12, 2026, 8:05 AM EDT · 4 months ago Treace Medical Concepts, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
May 8, 2026, 7:05 AM EDT · 5 months ago Treace Medical Concepts Reports First Quarter 2026 Financial Results
Apr 24, 2026, 7:05 AM EDT · 5 months ago Treace to Report First Quarter 2026 Financial Results on May 8, 2026
Apr 7, 2026, 9:04 AM EDT · 6 months ago Treace Announces First Surgical Cases with the SuperBite™ Compression Screw System
2026-03-02T14:12:23.000Z · 7 months ago Treace Medical price target lowered to $2.25 from $2.50 at UBS
2026-03-02T13:59:33.000Z · 7 months ago Treace Medical price target lowered to $7 from $7.50 at Lake Street
Feb 27, 2026, 7:05 AM EST · 7 months ago Treace Medical Concepts Reports Fourth Quarter and Full-Year 2025 Financial Results
2026-02-24T12:45:38.000Z · 7 months ago Treace Medical to highlight new product innovations, present data at ACFAS
Feb 24, 2026, 7:05 AM EST · 7 months ago Treace Highlights New Product Innovations and Updated Positive Clinical Study Data at the 2026 ACFAS Annual Scientific Conference
Feb 12, 2026, 5:13 PM EST · 7 months ago Treace Updates Date of Fourth Quarter and Full-Year 2025 Financial Results Release to February 27, 2026
Jan 13, 2026, 7:05 AM EST · 8 months ago Treace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2025 Revenue
2026-01-08T21:45:15.000Z · 9 months ago Treace Medical reports completion of first Lapiplasty Lightning technology case
Jan 8, 2026, 4:05 PM EST · 9 months ago Treace Announces First Surgical Case Utilizing Lapiplasty® Lightning™ Technology
Nov 7, 2025, 8:05 AM EST · 11 months ago Treace Announces Participation in Two Upcoming Investor Conferences
Oct 23, 2025, 4:05 PM EDT · 11 months ago Treace to Report Third Quarter 2025 Financial Results on November 6, 2025
Sep 10, 2025, 7:05 AM EDT · 1 year ago Treace Highlights New Product Innovations and Updated Positive Clinical Study Data at the 2025 American Orthopaedic Foot & Ankle Society Annual Meeting
Aug 7, 2025, 4:05 PM EDT · 1 year ago Treace Medical Concepts Reports Second Quarter 2025 Financial Results
Aug 7, 2025, 4:01 PM EDT · 1 year ago Treace Medical to Host Investor Day Highlighting New Products on September 3, 2025
Jul 1, 2025, 11:07 AM EDT · 1 year ago Notice to Long-Term Shareholders of Maison Solutions Inc. (NASDAQ: MSS); Napco Security Technologies, Inc. (NASDAQ: NSSC); Treace Medical Concepts, Inc. (NASDAQ: TMCI); and Virtu Financial Inc. (NYSE: VIRT): Grabar Law Office is Investigating Claims on Yo MSS NSSC VIRT
Jun 5, 2025, 1:00 PM EDT · 1 year ago Treace Files Patent Infringement Suit Against Zimmer Biomet to Protect Lapiplasty® Bunion Technology